Literature DB >> 24935567

Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection.

Vahdat Poortahmasebi1, Seyed Moayed Alavian, Hossein Keyvani, Mehdi Norouzi, Mahmood Mahmoodi, Seyed Mohammad Jazayeri.   

Abstract

BACKGROUND: In chronic hepatitis B (CHB), the presence of hepatic steatosis (HS) seems to be associated with known host and viral factors which may influence the long-term prognosis of chronic hepatitis B (CHB), probably leading to cirrhosis and hepatocellular carcinoma (HCC). Different from chronic hepatitis C (CHC), factors associated with HS in CHB are not clearly explored.
MATERIALS AND METHODS: 160 CHB patients were divided into two groups depending on the results of liver biopsy. Group I consisted of 71 patients with confirmed steatosis. Group II comprised 89 patients without steatosis. The groups were compared in terms of basal characteristics, body mass index (BMI), liver enzymes (ALT, AST, ALP), serum fasting blood sugar (FBS) and lipids, hepatitis B e antigen (HBeAg), viral load, and histological findings.
RESULTS: In terms of host factors, male gender, older age, BMI, high serum FBS and lipid levels were associated with HS. On the other hand, ALT levels, the HAI scores of necroinflammation and stage of fibrosis did not associate with HS. On multivariate analysis, parameters of sex, BMI, cholesterol and FBS levels were independently associated with HS. Regarding viral factors, HBeAg negativity was significantly associated with HS (81.7%, p value 0.006), but not HBV DNA level (p value 0.520).
CONCLUSIONS: HS in CHB appears to be unrelated to the status of HBV replication. However, fibrosis progression in CHB is related to variable host factors. HS may be enhanced through these factors in HBV chronic patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24935567     DOI: 10.7314/apjcp.2014.15.9.3879

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Preventive activity of banana peel polyphenols on CCl4-induced experimental hepatic injury in Kunming mice.

Authors:  Rui Wang; Xia Feng; Kai Zhu; Xin Zhao; Huayi Suo
Journal:  Exp Ther Med       Date:  2016-03-11       Impact factor: 2.447

Review 2.  Hepatitis B and concomitant hepatic steatosis.

Authors:  Chong Teik Lim; Rajneesh Kumar
Journal:  Ann Transl Med       Date:  2017-02

3.  Does Hepatic Steatosis Influence the Virological Response with Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir Disoproxil Fumarate?

Authors:  Roni Atalay; Süleyman Sayar; Fatma Gülçiçek Ayrancı; Şüheda Çakmak; İbrahim Halil Tanboğa; Levent Doğanay; Kamil Özdil
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

4.  Prevalence of hepatic steatosis and associated factors in Iranian patients with chronic hepatitis C.

Authors:  Vahdat Poortahmasebi; Mohammad Sajad Emami Aleagha; Mehdi Amiri; Mostafa Qorbani; Mohammad Farahmand; Hamid Asayesh; Seyed Moayed Alavian
Journal:  Med J Islam Repub Iran       Date:  2016-02-07

5.  A case-control study of risk factors for hepatitis B infection: A regional report among Isfahanian adults.

Authors:  Behrooz Ataei; Sayed Moayed Alavian; Faramarz Shahriari-Fard; Abbas Ali Rabiei; Ali Safaei; Ali Rabiei; Mehdi Ataei
Journal:  J Res Med Sci       Date:  2019-03-25       Impact factor: 1.852

6.  Serum apolipoprotein C3 levels are negatively associated with hepatitis B virus DNA in HBeAg-negative chronic hepatitis B patients.

Authors:  Yu Cui; Xiang-Dan Cui; Meng Xu; Min Fang; Mei-Juan Cai
Journal:  Lipids Health Dis       Date:  2019-06-11       Impact factor: 3.876

7.  Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.

Authors:  Sami A Gabr; Ahmad H Alghadir; Ahmed A Allam; Jamaan Ajarem; Ghada Al-Basher; Mostafa A Abdel-Maksoud; Ayman A Ghfar; Alaa Aboud
Journal:  Clin Interv Aging       Date:  2016-05-04       Impact factor: 4.458

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.